262 related articles for article (PubMed ID: 25938853)
1. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
Kenner BJ; Chari ST; Cleeter DF; Go VL
Pancreas; 2015 Jul; 44(5):686-92. PubMed ID: 25938853
[TBL] [Abstract][Full Text] [Related]
2. Early detection of sporadic pancreatic cancer: summative review.
Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D
Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254
[TBL] [Abstract][Full Text] [Related]
3. Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers.
Kenner BJ; Go VLW; Chari ST; Goldberg AE; Rothschild LJ
Pancreas; 2017; 46(10):1238-1241. PubMed ID: 28953187
[TBL] [Abstract][Full Text] [Related]
4. Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review.
Kenner B; Chari ST; Kelsen D; Klimstra DS; Pandol SJ; Rosenthal M; Rustgi AK; Taylor JA; Yala A; Abul-Husn N; Andersen DK; Bernstein D; Brunak S; Canto MI; Eldar YC; Fishman EK; Fleshman J; Go VLW; Holt JM; Field B; Goldberg A; Hoos W; Iacobuzio-Donahue C; Li D; Lidgard G; Maitra A; Matrisian LM; Poblete S; Rothschild L; Sander C; Schwartz LH; Shalit U; Srivastava S; Wolpin B
Pancreas; 2021 Mar; 50(3):251-279. PubMed ID: 33835956
[TBL] [Abstract][Full Text] [Related]
5. Early Detection of Pancreatic Cancer-a Defined Future Using Lessons From Other Cancers: A White Paper.
Kenner BJ; Chari ST; Maitra A; Srivastava S; Cleeter DF; Go VL; Rothschild LJ; Goldberg AE
Pancreas; 2016 Sep; 45(8):1073-9. PubMed ID: 27518362
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer and cancer screening programs: from nihilism to hope.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
[No Abstract] [Full Text] [Related]
8. Advances in pancreatic cancer research: moving towards early detection.
He XY; Yuan YZ
World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer.
Gayral M; Jo S; Hanoun N; Vignolle-Vidoni A; Lulka H; Delpu Y; Meulle A; Dufresne M; Humeau M; Chalret du Rieu M; Bournet B; Sèlves J; Guimbaud R; Carrère N; Buscail L; Torrisani J; Cordelier P
World J Gastroenterol; 2014 Aug; 20(32):11199-209. PubMed ID: 25170204
[TBL] [Abstract][Full Text] [Related]
10. Early detection of sporadic pancreatic cancer: time for change.
Frič P; Šedo A; Škrha J; Bušek P; Laclav M; Škrha P; Zavoral M
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):885-891. PubMed ID: 28471824
[TBL] [Abstract][Full Text] [Related]
11. Early Detection of Pancreatic Cancer: Opportunities and Challenges.
Singhi AD; Koay EJ; Chari ST; Maitra A
Gastroenterology; 2019 May; 156(7):2024-2040. PubMed ID: 30721664
[TBL] [Abstract][Full Text] [Related]
12. Metastatic Pancreatic Cancer.
Hogendorf P; Durczyński A; Strzelczyk J
J Invest Surg; 2018 Apr; 31(2):151-152. PubMed ID: 28267398
[No Abstract] [Full Text] [Related]
13. [Pancreatic cancer- a curable disease].
Limani P; Samaras P; Lesurtel M; Graf R; DeOliveira ML; Petrowsky H; Clavien PA
Praxis (Bern 1994); 2015 Apr; 104(9):453-60. PubMed ID: 25900693
[TBL] [Abstract][Full Text] [Related]
14. The need for effective pancreatic cancer detection and management: a biomarker-based strategy.
Crawley AS; O'Kennedy RJ
Expert Rev Mol Diagn; 2015; 15(10):1339-53. PubMed ID: 26394703
[TBL] [Abstract][Full Text] [Related]
15. Genetics of Familial and Sporadic Pancreatic Cancer.
Wood LD; Yurgelun MB; Goggins MG
Gastroenterology; 2019 May; 156(7):2041-2055. PubMed ID: 30660730
[TBL] [Abstract][Full Text] [Related]
16. The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.
Thompson ED; Roberts NJ; Wood LD; Eshleman JR; Goggins MG; Kern SE; Klein AP; Hruban RH
Mod Pathol; 2020 Dec; 33(12):2544-2563. PubMed ID: 32704031
[TBL] [Abstract][Full Text] [Related]
17. Molecular detection of pancreatic neoplasia: Current status and future promise.
Majumder S; Chari ST; Ahlquist DA
World J Gastroenterol; 2015 Oct; 21(40):11387-95. PubMed ID: 26526068
[TBL] [Abstract][Full Text] [Related]
18. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
19. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.
Maker AV; Carrara S; Jamieson NB; Pelaez-Luna M; Lennon AM; Dal Molin M; Scarpa A; Frulloni L; Brugge WR
J Am Coll Surg; 2015 Feb; 220(2):243-53. PubMed ID: 25592469
[No Abstract] [Full Text] [Related]
20. Precursors of pancreatic cancer.
Frič P; Škrha J; Šedo A; Bušek P; Laclav M; Bunganič B; Zavoral M
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):e13-e18. PubMed ID: 28009716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
